Hepatitis :: Vaccine 95.5% effective against neglected hepatitis E

A new candidate vaccine against hepatitis E, developed collaboratively by GlaxoSmithKline (GSK) and the Walter Reed Army Institute of Research (WRAIR), was found to be 95.5% effective in a Phase Two trial, according to a study to be published in the New England Journal of Medicine.

Brain Cancer :: Avastin can fight brain cancer

Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.

Cancer :: Breast, prostate cancer resources in Spanish

In an effort to reach a greater audience, and help patients and their families understand their cancer treatment options, the American Society for Therapeutic Radiology and Oncology now offers Spanish versions of their popular brochures Radiation Therapy for Breast Cancer and Radiation Therapy for Prostate Cancer.

Cell Phones :: Health application for cell phones

Mayo Clinic has collaborated with Digital Cyclone, Inc., a Minnesota-based subsidiary of Garmin, Ltd., to launch a software application that delivers an array of health information and tools directly to cellular phones.

Sarcoma :: Childhood cancer survivors at increased risk of sarcoma

Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma — a cancer of connective or supportive tissue such as bone, fat, or muscle — compared with the general population, according to a study in the February 21 Journal of the National Cancer Institute.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack